
With turnover of $46 billion, diabetes is a massive and extremely lucrative market.
Companies are developing drugs that are increasingly expensive and constantly promising miracle cures with patients either taking too many drugs or no longer being able to afford them and the only ones benefiting seem to be pharmaceutical companies.
Filmed on three continents, this documentary features industry whistle blowers, patients, researchers and medical professionals. It also confronts pharmaceutical companies about their responsibility for the situation.